Ironwood Pharmaceuticals Inc.
10/10/2025 | Press release | Distributed by Public on 10/10/2025 05:06
Management Change/Compensation (Form 8-K)
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On October 7, 2025, Andrew Dreyfus provided notice of his resignation from the Board of Directors of Ironwood Pharmaceuticals, Inc. (the "Company"), effective November 1, 2025. Mr. Dreyfus' decision to resign is due to his appointment as President and Chief Executive Officer of the National Institute for Health Care Management (NIHCM) Foundation and was not a result of any disagreement with the Company or any matter relating to the Company's operations, policies or practices. The Company thanks Mr. Dreyfus for his service and the many contributions he made to the Company during his tenure on the Board of Directors.
Ironwood Pharmaceuticals Inc. published this content on October 10, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on October 10, 2025 at 11:06 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]